1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Integrated CT‑Linac Consumption Value by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 C‑arm Integrated CT‑Linac
  • 1.3.3 Ring‑shaped Integrated CT‑Linac
• 1.4 Market Analysis by Application
  • 1.4.1 Overview: Global Integrated CT‑Linac Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.4.2 Online Adaptive Radiotherapy
  • 1.4.3 One‑Stop Radiotherapy
• 1.5 Global Integrated CT‑Linac Market Size & Forecast
  • 1.5.1 Global Integrated CT‑Linac Consumption Value (2021 & 2025 & 2032)
  • 1.5.2 Global Integrated CT‑Linac Sales Quantity (2021-2032)
  • 1.5.3 Global Integrated CT‑Linac Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 Shanghai United Imaging Healthcare Co., Ltd.
  • 2.1.1 Shanghai United Imaging Healthcare Co., Ltd. Details
  • 2.1.2 Shanghai United Imaging Healthcare Co., Ltd. Major Business
  • 2.1.3 Shanghai United Imaging Healthcare Co., Ltd. Integrated CT‑Linac Product and Services
  • 2.1.4 Shanghai United Imaging Healthcare Co., Ltd. Integrated CT‑Linac Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Shanghai United Imaging Healthcare Co., Ltd. Recent Developments/Updates

3 Competitive Environment: Integrated CT‑Linac by Manufacturer

• 3.1 Global Integrated CT‑Linac Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global Integrated CT‑Linac Revenue by Manufacturer (2021-2026)
• 3.3 Global Integrated CT‑Linac Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of Integrated CT‑Linac by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 Integrated CT‑Linac Manufacturer Market Share in 2025
  • 3.4.3 Top 6 Integrated CT‑Linac Manufacturer Market Share in 2025
• 3.5 Integrated CT‑Linac Market: Overall Company Footprint Analysis
  • 3.5.1 Integrated CT‑Linac Market: Region Footprint
  • 3.5.2 Integrated CT‑Linac Market: Company Product Type Footprint
  • 3.5.3 Integrated CT‑Linac Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Integrated CT‑Linac Market Size by Region
  • 4.1.1 Global Integrated CT‑Linac Sales Quantity by Region (2021-2032)
  • 4.1.2 Global Integrated CT‑Linac Consumption Value by Region (2021-2032)
  • 4.1.3 Global Integrated CT‑Linac Average Price by Region (2021-2032)
• 4.2 North America Integrated CT‑Linac Consumption Value (2021-2032)
• 4.3 Europe Integrated CT‑Linac Consumption Value (2021-2032)
• 4.4 Asia-Pacific Integrated CT‑Linac Consumption Value (2021-2032)
• 4.5 South America Integrated CT‑Linac Consumption Value (2021-2032)
• 4.6 Middle East & Africa Integrated CT‑Linac Consumption Value (2021-2032)

5 Market Segment by Type

• 5.1 Global Integrated CT‑Linac Sales Quantity by Type (2021-2032)
• 5.2 Global Integrated CT‑Linac Consumption Value by Type (2021-2032)
• 5.3 Global Integrated CT‑Linac Average Price by Type (2021-2032)

6 Market Segment by Application

• 6.1 Global Integrated CT‑Linac Sales Quantity by Application (2021-2032)
• 6.2 Global Integrated CT‑Linac Consumption Value by Application (2021-2032)
• 6.3 Global Integrated CT‑Linac Average Price by Application (2021-2032)

7 North America

• 7.1 North America Integrated CT‑Linac Sales Quantity by Type (2021-2032)
• 7.2 North America Integrated CT‑Linac Sales Quantity by Application (2021-2032)
• 7.3 North America Integrated CT‑Linac Market Size by Country
  • 7.3.1 North America Integrated CT‑Linac Sales Quantity by Country (2021-2032)
  • 7.3.2 North America Integrated CT‑Linac Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe Integrated CT‑Linac Sales Quantity by Type (2021-2032)
• 8.2 Europe Integrated CT‑Linac Sales Quantity by Application (2021-2032)
• 8.3 Europe Integrated CT‑Linac Market Size by Country
  • 8.3.1 Europe Integrated CT‑Linac Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe Integrated CT‑Linac Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific Integrated CT‑Linac Sales Quantity by Type (2021-2032)
• 9.2 Asia-Pacific Integrated CT‑Linac Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific Integrated CT‑Linac Market Size by Region
  • 9.3.1 Asia-Pacific Integrated CT‑Linac Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific Integrated CT‑Linac Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America Integrated CT‑Linac Sales Quantity by Type (2021-2032)
• 10.2 South America Integrated CT‑Linac Sales Quantity by Application (2021-2032)
• 10.3 South America Integrated CT‑Linac Market Size by Country
  • 10.3.1 South America Integrated CT‑Linac Sales Quantity by Country (2021-2032)
  • 10.3.2 South America Integrated CT‑Linac Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa Integrated CT‑Linac Sales Quantity by Type (2021-2032)
• 11.2 Middle East & Africa Integrated CT‑Linac Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa Integrated CT‑Linac Market Size by Country
  • 11.3.1 Middle East & Africa Integrated CT‑Linac Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa Integrated CT‑Linac Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 Integrated CT‑Linac Market Drivers
• 12.2 Integrated CT‑Linac Market Restraints
• 12.3 Integrated CT‑Linac Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Integrated CT‑Linac and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Integrated CT‑Linac
• 13.3 Integrated CT‑Linac Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Integrated CT‑Linac Typical Distributors
• 14.3 Integrated CT‑Linac Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Integrated CT‑Linac market size was valued at US$ 71.00 million in 2025 and is forecast to a readjusted size of US$ 2376 million by 2032 with a CAGR of 70.8% during review period.
Integrated CT‑Linac is a high‑end integrated radiotherapy device that deeply integrates a diagnostic CT imaging system and a radiotherapy linear accelerator onto one single platform.Its core characteristic is that the device enables a continuous closed‑loop workflow under the same treatment coordinate system, treatment couch and unified software, including diagnostic‑level CT image acquisition, tumor and organ‑at‑risk identification, patient positioning correction, dose evaluation, online adaptive replanning and precise irradiation.It thereby provides key technical support for high‑precision CT image‑guided radiotherapy, online adaptive radiotherapy and one‑stop radiotherapy.In 2025, the global sales volume of Integrated CT‑Linac was approximately 21 units, with an average transaction price of about 3.287 million US dollars per unit, and the gross profit margin was around 47%.
The Integrated CT‑Linac is currently transitioning from technology validation to high-end clinical adoption. Its market value lies not in replacing conventional linear accelerators across the board, but in reengineering workflows for highly complex radiotherapy.By integrating diagnostic-grade CT, patient positioning, dose evaluation, online adaptation, and treatment delivery onto a single platform, it aligns perfectly with the trends toward precision radiotherapy, one-stop workflows, and personalized treatment.In the foreseeable future, this market is more likely to be first adopted by leading cancer centers, university hospitals, and radiotherapy platforms pursuing differentiated capabilities, rather than experiencing rapid universal procurement.Its core competitiveness rests on high-quality imaging and closed-loop workflows. However, commercial expansion remains constrained by high capital investment, departmental workflow restructuring, software and quality assurance requirements, as well as competitive pressure from advanced CBCT adaptive systems and MR-Linac.Overall, the CT‑Linac represents a strategic niche segment characterized by high barriers, strong clinical drive, and a highly concentrated supplier base.
This report is a detailed and comprehensive analysis for global Integrated CT‑Linac market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Integrated CT‑Linac market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Integrated CT‑Linac market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Integrated CT‑Linac market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Integrated CT‑Linac market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Integrated CT‑Linac
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Integrated CT‑Linac market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shanghai United Imaging Healthcare Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Integrated CT‑Linac market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
C‑arm Integrated CT‑Linac
Ring‑shaped Integrated CT‑Linac
Market segment by Application
Online Adaptive Radiotherapy
One‑Stop Radiotherapy
Major players covered
Shanghai United Imaging Healthcare Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Integrated CT‑Linac product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Integrated CT‑Linac, with price, sales quantity, revenue, and global market share of Integrated CT‑Linac from 2021 to 2026.
Chapter 3, the Integrated CT‑Linac competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Integrated CT‑Linac breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Integrated CT‑Linac market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Integrated CT‑Linac.
Chapter 14 and 15, to describe Integrated CT‑Linac sales channel, distributors, customers, research findings and conclusion.